Related references
Note: Only part of the references are listed.Tripartite-motif proteins and innate immune regulation
Finlay W. McNab et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Thomas Pertel et al.
NATURE (2011)
Interaction of Vpx and Apolipoprotein B mRNA-editing Catalytic Polypeptide 3 Family Member A (APOBEC3A) Correlates with Efficient Lentivirus Infection of Monocytes
Andre Berger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Nicolas Manel et al.
NATURE (2010)
Targeting early infection to prevent HIV-1 mucosal transmission
Ashley T. Haase
NATURE (2010)
Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
David Perez-Caballero et al.
CELL (2009)
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants
Massimo Pizzato et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Cleavage of IPS-1 in Cells Infected with Human Rhinovirus
Jennifer Drahos et al.
JOURNAL OF VIROLOGY (2009)
Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism
Janet L. Douglas et al.
JOURNAL OF VIROLOGY (2009)
RIG-I is cleaved during picornavirus infection
Paola M. Barral et al.
VIROLOGY (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation
Bastien Mangeat et al.
PLOS PATHOGENS (2009)
Vpu Antagonizes BST-2-Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking
Richard S. Mitchell et al.
PLOS PATHOGENS (2009)
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein
Nanette Van Damme et al.
CELL HOST & MICROBE (2008)
Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages
Mikako Fujita et al.
JOURNAL OF VIROLOGY (2008)
Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 Vpx Function in Human Myeloid Cells
Caroline Goujon et al.
JOURNAL OF VIROLOGY (2008)
HIV immunology needs a new direction
Ruslan Medzhitov et al.
NATURE (2008)
The ties that bind a virus to the cell
Robert P. Kruger
CELL (2008)
TRIM E3 ligases interfere with early and late stages of the retroviral life cycle
Pradeep D. Uchil et al.
PLOS PATHOGENS (2008)
HIV-I Vif, APOBEC, and intrinsic immunity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2008)
Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction
Natalia Sharova et al.
PLOS PATHOGENS (2008)
Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection
Smita Srivastava et al.
PLOS PATHOGENS (2008)
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil et al.
NATURE (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
DDB1 and Cu14A are required for human immunodeficiency virus type 1 vpr-induced G2 arrest
Lindi Tan et al.
JOURNAL OF VIROLOGY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
The HIV1 protein vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor
Xiaoyun Wen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle
Kasia Hrecka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase
Jean-Philippe Belzile et al.
PLOS PATHOGENS (2007)
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Gang Peng et al.
BLOOD (2007)
An atomic model of the interferon-β enhanceosome
Daniel Panne et al.
CELL (2007)
HIV-I Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
Jason L. DeHart et al.
VIROLOGY JOURNAL (2007)
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1
Baerbel Schroefelbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Primitive hematopoietic ceHs resist HIV-1 infection via p21Waf1/Cip1/Sdi1
Jielin Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection
Jeremy Luban
JOURNAL OF VIROLOGY (2007)
HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase
Erwann Le Rouzic et al.
CELL CYCLE (2007)
SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells
Caroline Goujon et al.
RETROVIROLOGY (2007)
Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1
Michael Schindler et al.
CELL (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dissociation of a MAVS/IPS-1/VISA/Cardif-1KKε molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage
Rongtuan Lin et al.
JOURNAL OF VIROLOGY (2006)
With a little help from a friend:: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC
C. Goujon et al.
GENE THERAPY (2006)
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
YM Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells
M Belshan et al.
VIROLOGY (2006)
Retroviral infection of non-dividing cells: Old and new perspectives
M Yamashita et al.
VIROLOGY (2006)
The cell cycle independence of HIV infections is not determined by known karyophilic viral elements
Masahiro Yamashita et al.
PLOS PATHOGENS (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan et al.
NATURE (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF
K Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA
L Berthoux et al.
JOURNAL OF VIROLOGY (2004)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
M Marin et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism
A Papkalla et al.
JOURNAL OF VIROLOGY (2002)
Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection
YJ Zhang et al.
JOURNAL OF VIROLOGY (2002)
High levels of transduction of human dendritic cells with optimized SIV vectors
PE Mangeot et al.
MOLECULAR THERAPY (2002)
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6Gag
Y Jenkins et al.
JOURNAL OF VIROLOGY (2001)
A quantitative assay for HIV DNA integration in vivo
SL Butler et al.
NATURE MEDICINE (2001)
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
D Nègre et al.
GENE THERAPY (2000)
Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells
JJ Hu et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
